Stent studies don't reflect 'real world' patients
Stroke-preventing devices are not being tested in people who resemble the patients most likely to receive them, a new study shows. The researchers looked at tests being done as part of "post-market surveillance studies," which test products that are already approved and in general use by the public. They found that patients who had stents placed into their neck in these studies were healthier than other patients in a broader nationwide registry of people who received stents. Yet the patients in the larger registry database who weren't in the post-marketing studies were 50% more likely to have had a stroke in the past, and were four times as likely to die in the hospital.
- How Top-Ranked MA Plans Earn Their Stars
- How Hospitals Can Become 'Upstreamists'
- Readmissions: No Quick Fix to Costly Hospital Challenge
- 4 Ways to Lower the Cost to Collect from Self-Pay Patients
- WellPoint Dominates Nearly Half of Markets, AMA Says
- CMS Offers Some ACOs $114M for 'Upfront' Costs
- 4 Tips for Managing Employed Physicians
- House Calls Key to Pioneer ACO Success
- Ebola: Second TX Nurse Diagnosed After Improper Protective Gear Application
- Providers Ask HHS to Address EHR Interoperability Barriers